These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 19795373)

  • 1. Correlation of endorectal 2D JPRESS findings with pathological Gleason scores in prostate cancer patients.
    Nagarajan R; Gomez AM; Raman SS; Margolis DJ; McClure T; Thomas MA
    NMR Biomed; 2010 Apr; 23(3):257-61. PubMed ID: 19795373
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Two-dimensional spectroscopic imaging for pretreatment evaluation of prostate cancer: comparison with the step-section histology after radical prostatectomy.
    Weis J; Ahlström H; Hlavcak P; Häggman M; Ortiz-Nieto F; Bergman A
    Magn Reson Imaging; 2009 Jan; 27(1):87-93. PubMed ID: 18599244
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 1H-MRSI of prostate cancer: the relationship between metabolite ratio and tumor proliferation.
    Wang XZ; Wang B; Gao ZQ; Liu JG; Liu ZQ; Niu QL; Sun ZK; Yuan YX
    Eur J Radiol; 2010 Feb; 73(2):345-51. PubMed ID: 19070978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contribution of Histopathologic Tissue Composition to Quantitative MR Spectroscopy and Diffusion-weighted Imaging of the Prostate.
    Kobus T; van der Laak JA; Maas MC; Hambrock T; Bruggink CC; Hulsbergen-van de Kaa CA; Scheenen TW; Heerschap A
    Radiology; 2016 Mar; 278(3):801-11. PubMed ID: 26418614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 2D JPRESS of human prostates using an endorectal receiver coil.
    Yue K; Marumoto A; Binesh N; Thomas MA
    Magn Reson Med; 2002 Jun; 47(6):1059-64. PubMed ID: 12111951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation of proton MR spectroscopic imaging with gleason score based on step-section pathologic analysis after radical prostatectomy.
    Zakian KL; Sircar K; Hricak H; Chen HN; Shukla-Dave A; Eberhardt S; Muruganandham M; Ebora L; Kattan MW; Reuter VE; Scardino PT; Koutcher JA
    Radiology; 2005 Mar; 234(3):804-14. PubMed ID: 15734935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transition zone prostate cancer: metabolic characteristics at 1H MR spectroscopic imaging--initial results.
    Zakian KL; Eberhardt S; Hricak H; Shukla-Dave A; Kleinman S; Muruganandham M; Sircar K; Kattan MW; Reuter VE; Scardino PT; Koutcher JA
    Radiology; 2003 Oct; 229(1):241-7. PubMed ID: 12920178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative (1) H MR spectroscopic imaging of the prostate gland using LCModel and a dedicated basis-set: correlation with histologic findings.
    García-Martín ML; Adrados M; Ortega MP; Fernández González I; López-Larrubia P; Viaño J; García-Segura JM
    Magn Reson Med; 2011 Feb; 65(2):329-39. PubMed ID: 20939087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative J-resolved prostate spectroscopy using two-dimensional prior-knowledge fitting.
    Lange T; Schulte RF; Boesiger P
    Magn Reson Med; 2008 May; 59(5):966-72. PubMed ID: 18429013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantification of metabolite concentrations in benign and malignant prostate tissues using 3D proton MR spectroscopic imaging.
    Weis J; von Below C; Tolf A; Ortiz-Nieto F; Wassberg C; Häggman M; Ladjevardi S; Ahlström H
    J Magn Reson Imaging; 2017 Apr; 45(4):1232-1240. PubMed ID: 27556571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of endorectal magnetic resonance spectroscopic imaging in two different Gleason scores in prostate cancer.
    Nagarajan R; Margolis D; McClure T; Raman S; Thomas MA
    Med Princ Pract; 2011; 20(5):444-8. PubMed ID: 21757934
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Three-dimensional proton magnetic resonance spectroscopic imaging with and without an endorectal coil: a prostate phantom study.
    Ma C; Chen L; Scheenen TW; Lu J; Wang J
    Acta Radiol; 2015 Nov; 56(11):1342-9. PubMed ID: 25348479
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peripheral zone prostate cancer. Pre-treatment evaluation with MR and 3D ¹H MR spectroscopic imaging: correlation with pathologic findings.
    Giusti S; Caramella D; Fruzzetti E; Lazzereschi M; Tognetti A; Bartolozzi C
    Abdom Imaging; 2010 Dec; 35(6):757-63. PubMed ID: 19756851
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proton two-dimensional chemical shift imaging for evaluation of prostate cancer: external surface coil vs. endorectal surface coil.
    Kaji Y; Wada A; Imaoka I; Matsuo M; Terachi T; Kobashi Y; Sugimura K; Fujii M; Maruyama K; Takizawa O
    J Magn Reson Imaging; 2002 Dec; 16(6):697-706. PubMed ID: 12451583
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo assessment of prostate cancer aggressiveness using magnetic resonance spectroscopic imaging at 3 T with an endorectal coil.
    Kobus T; Hambrock T; Hulsbergen-van de Kaa CA; Wright AJ; Barentsz JO; Heerschap A; Scheenen TW
    Eur Urol; 2011 Nov; 60(5):1074-80. PubMed ID: 21419565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anatomical and metabolic assessment of prostate using a 3-Tesla MR scanner with a custom-made external transceive coil: healthy volunteer study.
    Kaji Y; Kuroda K; Maeda T; Kitamura Y; Fujiwara T; Matsuoka Y; Tamura M; Takei N; Matsuda T; Sugimura K
    J Magn Reson Imaging; 2007 Mar; 25(3):517-26. PubMed ID: 17279524
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Citrate as an in vivo marker to discriminate prostate cancer from benign prostatic hyperplasia and normal prostate peripheral zone: detection via localized proton spectroscopy.
    Kurhanewicz J; Vigneron DB; Nelson SJ; Hricak H; MacDonald JM; Konety B; Narayan P
    Urology; 1995 Mar; 45(3):459-66. PubMed ID: 7533458
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MR spectroscopic imaging and diffusion-weighted imaging of prostate cancer with Gleason scores.
    Nagarajan R; Margolis D; Raman S; Sarma MK; Sheng K; King CR; Verma G; Sayre J; Reiter RE; Thomas MA
    J Magn Reson Imaging; 2012 Sep; 36(3):697-703. PubMed ID: 22581787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolite ratios in 1H MR spectroscopic imaging of the prostate.
    Kobus T; Wright AJ; Weiland E; Heerschap A; Scheenen TW
    Magn Reson Med; 2015 Jan; 73(1):1-12. PubMed ID: 24488656
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multidimensional MR spectroscopic imaging of prostate cancer in vivo.
    Thomas MA; Nagarajan R; Huda A; Margolis D; Sarma MK; Sheng K; Reiter RE; Raman SS
    NMR Biomed; 2014 Jan; 27(1):53-66. PubMed ID: 23904127
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.